150 related articles for article (PubMed ID: 33724031)
1. Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A
Comeo E; Trinh P; Nguyen AT; Nowell CJ; Kindon ND; Soave M; Stoddart LA; White JM; Hill SJ; Kellam B; Halls ML; May LT; Scammells PJ
J Med Chem; 2021 May; 64(10):6670-6695. PubMed ID: 33724031
[TBL] [Abstract][Full Text] [Related]
2. Development of Covalent, Clickable Probes for Adenosine A
Trinh PNH; Chong DJW; Leach K; Hill SJ; Tyndall JDA; May LT; Vernall AJ; Gregory KJ
J Med Chem; 2021 Jun; 64(12):8161-8178. PubMed ID: 34120444
[TBL] [Abstract][Full Text] [Related]
3. Subtype-Selective Fluorescent Ligands as Pharmacological Research Tools for the Human Adenosine A
Comeo E; Kindon ND; Soave M; Stoddart LA; Kilpatrick LE; Scammells PJ; Hill SJ; Kellam B
J Med Chem; 2020 Mar; 63(5):2656-2672. PubMed ID: 31887252
[TBL] [Abstract][Full Text] [Related]
4. Optimization of 2-Amino-4,6-diarylpyrimidine-5-carbonitriles as Potent and Selective A
Val C; Rodríguez-García C; Prieto-Díaz R; Crespo A; Azuaje J; Carbajales C; Majellaro M; Díaz-Holguín A; Brea JM; Loza MI; Gioé-Gallo C; Contino M; Stefanachi A; García-Mera X; Estévez JC; Gutiérrez-de-Terán H; Sotelo E
J Med Chem; 2022 Feb; 65(3):2091-2106. PubMed ID: 35068155
[TBL] [Abstract][Full Text] [Related]
5. NanoBiT Complementation to Monitor Agonist-Induced Adenosine A
Soave M; Kellam B; Woolard J; Briddon SJ; Hill SJ
SLAS Discov; 2020 Feb; 25(2):186-194. PubMed ID: 31583945
[TBL] [Abstract][Full Text] [Related]
6. Novel fluorescent triazinobenzimidazole derivatives as probes for labelling human A
Barresi E; Giacomelli C; Daniele S; Tonazzini I; Robello M; Salerno S; Piano I; Cosimelli B; Greco G; Da Settimo F; Martini C; Trincavelli ML; Taliani S
Bioorg Med Chem; 2018 Dec; 26(22):5885-5895. PubMed ID: 30415894
[TBL] [Abstract][Full Text] [Related]
7. Design and in Vivo Characterization of A
Tosh DK; Rao H; Bitant A; Salmaso V; Mannes P; Lieberman DI; Vaughan KL; Mattison JA; Rothwell AC; Auchampach JA; Ciancetta A; Liu N; Cui Z; Gao ZG; Reitman ML; Gavrilova O; Jacobson KA
J Med Chem; 2019 Feb; 62(3):1502-1522. PubMed ID: 30605331
[TBL] [Abstract][Full Text] [Related]
8. Identification of new potent A
Wei Y; Wang M; Li Y; Hong Z; Li D; Lin J
Eur J Med Chem; 2020 Feb; 187():111936. PubMed ID: 31855793
[TBL] [Abstract][Full Text] [Related]
9. Discovery of 1,3-diethyl-7-methyl-8-(phenoxymethyl)-xanthine derivatives as novel adenosine A
Harmse R; van der Walt MM; Petzer JP; Terre'Blanche G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5951-5955. PubMed ID: 27836398
[TBL] [Abstract][Full Text] [Related]
10. Structural Basis for Binding of Allosteric Drug Leads in the Adenosine A
Miao Y; Bhattarai A; Nguyen ATN; Christopoulos A; May LT
Sci Rep; 2018 Nov; 8(1):16836. PubMed ID: 30442899
[TBL] [Abstract][Full Text] [Related]
11. New Insights into Key Determinants for Adenosine 1 Receptor Antagonists Selectivity Using Supervised Molecular Dynamics Simulations.
Bolcato G; Bissaro M; Deganutti G; Sturlese M; Moro S
Biomolecules; 2020 May; 10(5):. PubMed ID: 32392873
[TBL] [Abstract][Full Text] [Related]
12. Structure-Based Design, Synthesis, and In Vivo Antinociceptive Effects of Selective A
Petrelli R; Scortichini M; Belardo C; Boccella S; Luongo L; Capone F; Kachler S; Vita P; Del Bello F; Maione S; Lavecchia A; Klotz KN; Cappellacci L
J Med Chem; 2018 Jan; 61(1):305-318. PubMed ID: 29257884
[TBL] [Abstract][Full Text] [Related]
13. Identification and optimization of substituted 5-aminopyrazoles as potent and selective adenosine A1 receptor antagonists.
Griebenow N; Bärfacker L; Meier H; Schneider D; Teusch N; Lustig K; Kast R; Kolkhof P
Bioorg Med Chem Lett; 2010 Oct; 20(19):5891-4. PubMed ID: 20728355
[TBL] [Abstract][Full Text] [Related]
14. A Taxicab geometry quantification system to evaluate the performance of in silico methods: a case study on adenosine receptors ligands.
Kuder KJ; Michalik I; Kieć-Kononowicz K; Kolb P
J Comput Aided Mol Des; 2020 Jun; 34(6):697-707. PubMed ID: 32112287
[TBL] [Abstract][Full Text] [Related]
15. Extracellular Loop 2 of the Adenosine A1 Receptor Has a Key Role in Orthosteric Ligand Affinity and Agonist Efficacy.
Nguyen AT; Baltos JA; Thomas T; Nguyen TD; Muñoz LL; Gregory KJ; White PJ; Sexton PM; Christopoulos A; May LT
Mol Pharmacol; 2016 Dec; 90(6):703-714. PubMed ID: 27683014
[TBL] [Abstract][Full Text] [Related]
16. Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands.
Baker JG; Middleton R; Adams L; May LT; Briddon SJ; Kellam B; Hill SJ
Br J Pharmacol; 2010 Feb; 159(4):772-86. PubMed ID: 20105183
[TBL] [Abstract][Full Text] [Related]
17. 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists.
Ferguson GN; Valant C; Horne J; Figler H; Flynn BL; Linden J; Chalmers DK; Sexton PM; Christopoulos A; Scammells PJ
J Med Chem; 2008 Oct; 51(19):6165-72. PubMed ID: 18771255
[TBL] [Abstract][Full Text] [Related]
18. Probe dependence of allosteric enhancers on the binding affinity of adenosine A
Cooper SL; Soave M; Jörg M; Scammells PJ; Woolard J; Hill SJ
Br J Pharmacol; 2019 Apr; 176(7):864-878. PubMed ID: 30644086
[TBL] [Abstract][Full Text] [Related]
19. Influence of binding affinity and blood plasma level on cerebral pharmacokinetics and PET imaging characteristics of two novel xanthine PET radioligands for the A
Schneider D; Oskamp A; Holschbach M; Neumaier B; Bier D; Bauer A
Nucl Med Biol; 2020; 82-83():1-8. PubMed ID: 31838339
[TBL] [Abstract][Full Text] [Related]
20. Pyrazolo[1',5':1,6]pyrimido[4,5-d]pyridazin-4(3H)-ones as selective human A(1) adenosine receptor ligands.
Giovannoni MP; Vergelli C; Cilibrizzi A; Crocetti L; Biancalani C; Graziano A; Dal Piaz V; Loza MI; Cadavid MI; Díaz JL; Gavaldà A
Bioorg Med Chem; 2010 Nov; 18(22):7890-9. PubMed ID: 20937560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
